Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.01 (0.45%)
Bid:
2.01
Ask:
2.19
Spread: 0.18 (8.955%)
Market Cap: £44.34m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

bioMSAR™ Development Update

5 Dec 2024 07:00

RNS Number : 8801O
Quadrise PLC
05 December 2024
 

5 December 2024

 

Quadrise Plc ("Quadrise" or the "Company")

 

bioMSAR™ Development Update and Progress towards bioMSAR™ Zero

 

Quadrise Plc (AIM: QED), the transition technology provider for a cleaner planet, is pleased to confirm positive engine testing results for new bioMSAR prototypes, including our first with 100% biofuel, and to provide an update on related biofuel testing with project partners.

 

The objective of the Company's biofuel development programme is to supply the marine and industrial sectors with sustainable biofuels that are lower in cost, more efficient, safer yet simple to use, and which minimise harmful emissions. Our product development goal is to stay ahead of marine legislation and market requirements with the aim of offering an entirely fossil-free 'bioMSAR Zero™' fuel at commercial scale by 2030, which will future-proof our technology and allow access to new markets.

 

The recent engine tests were carried out on the Company's 40kW 4-Stroke Cummins diesel engine generator installed at Aquafuel Research Limited using bioMSAR formulations prepared and lab tested at the Quadrise Research Facility.

 

The results confirmed that the Quadrise emulsion technology platform can be used to produce viable non-fossil and low-fossil fuels which lower emissions, improve engine efficiency and reduce fuel costs.

 

Further testing on biofuel blendstocks and bioMSAR™ prototypes is now planned as Quadrise accelerates progress towards a commercial bioMSAR™ Zero, which we aim to provide to our clients well in advance of our original 2030 target.

 

Commenting on the update, Jason Miles, Chief Executive Officer of Quadrise, said:

 

"These hugely encouraging results demonstrate the capability of the Quadrise team and the adaptability of our unique proprietary oil-in-water emulsion chemistry, squarely positioning the Company to address the ongoing decarbonisation of the marine sector.

 

Our versatile technology mixes both water and oil soluble blendstocks to produce stable biofuels, increasing the opportunity to access abundant waste bio-energy resources that do not have economic higher-value applications. This enables us to customise formulations based on feedstock availability, cost and intended applications around the world.

 

Quadrise fuels have significantly enhanced performance and lower consumption costs per unit energy consumed. They can be supplied at scale to the marine sector using existing bunkering infrastructure and vessels, helping the sector to meet climate targets whilst extending the operating life of assets, which can be easily converted to our technology.

All of this places Quadrise in a unique position as a transition technology partner, for clients in energy-intensive sectors as well as biofuel suppliers.

 

Quadrise and our development partners are excited by these results, and we look forward to progressing the testing programme to the next stages, with the intention of launching our first fossil-free bioMSAR Zero™ product at commercial scale well in advance of 2030."

 

About the latest developments:

 

bioMSAR™ Zero ("B100") blended using Sustainable Methyl Esters and Glycerine

 

During the year, Quadrise developed a bioMSAR™ Zero blend which combines 100% sustainable ("second generation") waste-based methyl esters and glycerine as a highly stable emulsion biofuel.

 

Methyl esters have been used in fuel blends for several decades and are produced from a diverse range of feedstocks such as natural fats or oils. Methyl esters have properties similar to conventional diesel fuel, making them suitable for use in diesel engines without significant modifications.

 

Our blend of 'B100' bioMSAR™ Zero is expected to be more cost-effective than equivalent B100 biofuel blends in use today due to the lower price of the biofuel components that we can use and the enhanced engine performance that the fuel delivers.

 

The Company's Lifecycle Analysis revealed that the blend offers 85% lower carbon dioxide ("CO2") equivalent emissions compared to conventional marine fuels. This is comparable with the 100% biogenic ("B100") marine fuels that are being used today.

 

Engine testing results were compared against automotive diesel performance and demonstrated:

 

· Engine efficiency improvements of 9-10%, reducing fuel consumption costs and emissions.

· Carbon monoxide ("CO") and Nitrogen oxide ("NOx") emission reductions of 93% and 18% respectively, and

· Negligible visible smoke from the exhaust.

 

Following these positive engine test results, Quadrise intends to scale-up testing of this bioMSAR™ Zero formulation in conjunction with marine project stakeholders and a major diesel engine manufacturer in due course.

 

bioMSAR™ ("B50") blended using Marine B50 (50% HFO with 50% Methyl Esters)

 

Following the positive results using a B30 blend announced in December 2023, Quadrise have tested bioMSAR™ formulations combining 67% B50, which is a blend in itself (of 50% methyl esters blended with 50% fuel oil), with 33% water. In comparison to conventional marine fuels, the B50 bioMSAR™ blend offers 39% lower CO2 equivalent emissions.

 

In this second phase of Cummins engine testing, B50 MSAR® was compared with diesel with results demonstrating:

 

· Engine efficiency improvements of 7-8%, reducing fuel consumption costs and CO2 emissions.

· Carbon monoxide ("CO") and Nitrogen oxide ("NOx") emission reductions of 87% and 29% respectively, with negligible smoke visible from the exhaust.

 

The latest results are published in more detail on the Quadrise website at: https://www.quadrise.com/references/biomsar-nextgen

 

Related bioMSAR™ Developments

 

In addition to the methyl esters development program described above, work is progressing positively under our JDA's with BTG Bioliquids BV ("BTL") and Vertoro BV ("Vertoro") on developing bioMSAR™ Zero formulations using BTL's pyrolysis sugars and Vertoro's crude sugar oil™ ("CSO™").

 

A pilot and engine test programme on bioMSAR™ Zero incorporating CSO™ is currently being planned which will investigate the performance of both premixed and 'blend-on-board' bioMSAR™ Zero with CSO. Upon successful completion, this formulation will then be tested at sea on-board a newly designed prototype motor yacht built for Vertoro by Focus Motor Yachts, with sea-testing expected to commence in Q2 2025.

 

Quadrise also continue to develop relationships with other suppliers who can provide sustainable bio-feedstocks on a commercial scale for future bioMSAR™ supply.

 

Further announcements will be made, as appropriate, in due course.

 

 

For additional information, please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cavendish Capital Markets Limited

+44 (0)20 7220 0500

Ben Jeynes

Katy Birkin

George Lawson

Joint Brokers

Shore Capital Stockbrokers Limited

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

+44 (0)20 7408 4090

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

 

+44 (0)20 3005 5000

 

Public & Investor Relations

 

 

Cutbill Jacoby

Andy Cutbill

Frankie Dundon

 

+44 (0)7841 576000

+44 (0)7312 274086

 

 

About Quadrise:

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to lower energy costs, pollution and greenhouse gas emissions today for the global power generation, shipping, industrial and oil industries.

Learn more at: www.quadrise.com

 

Follow us on social media:

LinkedIn: @Quadrise Plc

X (formerly Twitter): @QuadrisePlc

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAFALELELFAA
Date   Source Headline
15th Apr 20267:00 amRNSDirectorate change
23rd Mar 20267:00 amRNSInterim Results & Notice of Investor Presentation
19th Mar 20267:00 amRNSAppointment of Non-Executive Director
3rd Feb 20267:00 amRNS-RPublication of 2025 Sustainability Report
12th Jan 20267:00 amRNSExtension of Exclusive Agreement with Nouryon
9th Jan 20267:00 amRNSDirector/PDMR Shareholding and Directorate Change
4th Dec 202512:17 pmRNSDirector/PDMR Shareholding
28th Nov 20252:55 pmRNSResult of AGM
28th Nov 20257:00 amRNSAGM Statement
7th Nov 20253:01 pmRNSDirector/PDMR Shareholding
6th Nov 20251:46 pmRNSDirector/PDMR Shareholding
28th Oct 20255:23 pmRNSPosting of Annual Report and Notice of AGM
27th Oct 20257:00 amRNSIssue of Options and Director Dealing
13th Oct 20257:00 amRNSIssue of Share Options and Director/PDMR Dealing
29th Sep 20257:00 amRNSFinal Results and Notice of AGM
26th Sep 20257:00 amRNSValkor update
17th Sep 20257:00 amRNSSuccessful Sparkle Power Programme Testing
15th Sep 20257:00 amRNSCEO Appointment
18th Aug 20257:00 amRNSBusiness Update
25th Jul 20257:00 amRNSDirector / PDMR Shareholding
14th Jul 20258:00 amRNSDirector/PDMR Shareholding
4th Jul 202511:50 amRNSExercise of Options and Total Voting Rights
17th Jun 20257:00 amRNSJoint Development Agreement with Alder Energy LLC
10th Jun 20257:00 amRNSBusiness Update
23rd May 20257:00 amRNSExercise of Warrants
1st May 20257:01 amRNSTotal Voting Rights
1st May 20257:00 amRNSManagement Update
3rd Apr 20257:00 amRNSExercise of Share Options
1st Apr 20257:00 amRNSMAC2 Services Agreement
26th Mar 202512:46 pmRNSDirector/PDMR Shareholding
26th Mar 20257:00 amRNSLicella Joint Development Agreement
24th Mar 20257:00 amRNSInterim Results and Investor Presentation
13th Mar 20257:00 amRNS-RAppointment of Head of Marine
31st Jan 20257:00 amRNSResult of Retail Offer
30th Jan 20252:36 pmRNSIncrease of Retail Offer
28th Jan 20257:00 amRNSAppointment of Director
24th Jan 202510:04 amRNSRetail Offer - Notice of IMC Presentation
24th Jan 20257:05 amRNSRetail Offer
24th Jan 20257:00 amRNSResult of Placing and Subscription
23rd Jan 20254:51 pmRNSProposed Placing, Subscription and Retail Offer
15th Jan 20257:00 amRNSValkor License Revenues
16th Dec 20247:00 amRNSMaterial Transfer Agreement with Sparkle Power SA
5th Dec 20247:00 amRNS-RbioMSAR™ Development Update
26th Nov 20247:00 amRNSProject Agreement with MSC and Cargill
25th Nov 20247:00 amRNSCollaboration Agreement with Auramarine
22nd Nov 20244:57 pmRNSResult of AGM
22nd Nov 20247:00 amRNSAGM Statement
25th Oct 20244:05 pmRNSPosting of Annual Report & Notice of AGM
30th Sep 20247:00 amRNSFinal Results and Notice of AGM
2nd Aug 20247:00 amRNSIssue of Share Options and Director/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.